{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:35:13Z","timestamp":1783006513195,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11060-024-04872-3","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T09:11:19Z","timestamp":1731316279000},"page":"455-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology of glioblastoma in Pakistan: a secondary analysis of the Pakistan Brain Tumor Epidemiology Study (PBTES)"],"prefix":"10.1007","volume":"171","author":[{"given":"Hammad Atif","family":"Irshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Balaj Ali","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hamza","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashal Murad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ather","family":"Enam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"4872_CR1","doi-asserted-by":"crossref","unstructured":"Wirsching H-G, Galanis E, Weller M (2016) Chap. 23 - Glioblastoma. In: Berger MS, Weller MBT-H of CN (eds) Gliomas. Elsevier, pp 381\u2013397","DOI":"10.1016\/B978-0-12-802997-8.00023-2"},{"key":"4872_CR2","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","volume":"80","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Preusser M, Roth P et al (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101896","journal-title":"Cancer Treat Rev"},{"key":"4872_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842\u20131850. https:\/\/doi.org\/10.1001\/jama.2013.280319","journal-title":"JAMA"},{"key":"4872_CR4","doi-asserted-by":"publisher","first-page":"e8195","DOI":"10.7759\/cureus.8195","volume":"12","author":"N Grech","year":"2020","unstructured":"Grech N, Dalli T, Mizzi S et al (2020) Rising incidence of Glioblastoma Multiforme in a well-defined Population. Cureus 12:e8195. https:\/\/doi.org\/10.7759\/cureus.8195","journal-title":"Cureus"},{"key":"4872_CR5","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"4872_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/0284186X.2014.975369","volume":"54","author":"T Asklund","year":"2015","unstructured":"Asklund T, Malmstr\u00f6m A, Bergqvist M et al (2015) Brain tumors in Sweden: data from a population-based registry 1999\u20132012. Acta Oncol (Madr) 54:377\u2013384. https:\/\/doi.org\/10.3109\/0284186X.2014.975369","journal-title":"Acta Oncol (Madr)"},{"key":"4872_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/2278-330X.187589","volume":"5","author":"A Dasgupta","year":"2016","unstructured":"Dasgupta A, Gupta T, Jalali R (2016) Indian data on central nervous tumors: a summary of published work. South Asian J Cancer 5:147\u2013153. https:\/\/doi.org\/10.4103\/2278-330X.187589","journal-title":"South Asian J Cancer"},{"key":"4872_CR8","doi-asserted-by":"publisher","first-page":"878425","DOI":"10.1155\/2012\/878425","volume":"2012","author":"F Ohka","year":"2012","unstructured":"Ohka F, Natsume A, Wakabayashi T (2012) Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int 2012:878425. https:\/\/doi.org\/10.1155\/2012\/878425","journal-title":"Neurol Res Int"},{"key":"4872_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"4872_CR10","doi-asserted-by":"publisher","unstructured":"Brown NF, Ottaviani D, Tazare J et al (2022) Survival outcomes and prognostic factors in Glioblastoma. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14133161","DOI":"10.3390\/cancers14133161"},{"issue":"Suppl 4","key":"4872_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.47391\/JPMA.11-S4-AKUB01","volume":"72","author":"SA Enam","year":"2022","unstructured":"Enam SA, Shah MM, Bajwa MH et al (2022) The Pakistan Brain Tumour Epidemiology Study. J Pak Med Assoc 72(Suppl 4):S4\u2013S11. https:\/\/doi.org\/10.47391\/JPMA.11-S4-AKUB01","journal-title":"J Pak Med Assoc"},{"issue":"Suppl 4","key":"4872_CR12","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.47391\/JPMA.11-S4-AKUB02","volume":"72","author":"E Baig","year":"2022","unstructured":"Baig E, Shah MM, Bajwa MH et al (2022) Conducting the Pakistan brain tumour epidemiology study - report on the methodology. J Pak Med Assoc 72(Suppl 4):S10\u2013S15. https:\/\/doi.org\/10.47391\/JPMA.11-S4-AKUB02","journal-title":"J Pak Med Assoc"},{"key":"4872_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4872_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","volume":"34","author":"KA McNeill","year":"2016","unstructured":"McNeill KA (2016) Epidemiology of brain tumors. Neurol Clin 34:981\u2013998. https:\/\/doi.org\/10.1016\/j.ncl.2016.06.014","journal-title":"Neurol Clin"},{"key":"4872_CR15","doi-asserted-by":"publisher","unstructured":"Tamimi AF, Juweid M (2017) Epidemiology and outcome of glioblastoma. Exon Publications, pp 143\u2013153. https:\/\/doi.org\/10.15586\/codon.glioblastoma.2017.ch8","DOI":"10.15586\/codon.glioblastoma.2017.ch8"},{"issue":"Suppl 2","key":"4872_CR16","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","volume":"15","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro Oncol 15(Suppl 2):ii1\u201356. https:\/\/doi.org\/10.1093\/neuonc\/not151","journal-title":"Neuro Oncol"},{"key":"4872_CR17","doi-asserted-by":"publisher","first-page":"vdab125","DOI":"10.1093\/noajnl\/vdab125","volume":"3","author":"M Kim","year":"2021","unstructured":"Kim M, Ladomersky E, Mozny A et al (2021) Glioblastoma as an age-related neurological disorder in adults. Neurooncol Adv 3:vdab125. https:\/\/doi.org\/10.1093\/noajnl\/vdab125","journal-title":"Neurooncol Adv"},{"key":"4872_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.20892\/j.issn.2095-3941.2022.0418","volume":"19","author":"Z Mo","year":"2022","unstructured":"Mo Z, Xin J, Chai R et al (2022) Epidemiological characteristics and genetic alterations in adult diffuse glioma in east Asian populations. Cancer Biol Med 19:1440\u20131459. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0418","journal-title":"Cancer Biol Med"},{"key":"4872_CR19","doi-asserted-by":"publisher","first-page":"vdab040","DOI":"10.1093\/noajnl\/vdab040","volume":"3","author":"TR Hodges","year":"2021","unstructured":"Hodges TR, Labak CM, Mahajan UV et al (2021) Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database. Neurooncol Adv 3:vdab040. https:\/\/doi.org\/10.1093\/noajnl\/vdab040","journal-title":"Neurooncol Adv"},{"key":"4872_CR20","first-page":"50","volume":"10","author":"PYM Woo","year":"2023","unstructured":"Woo PYM, Yau S, Lam T-C et al (2023) Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period. Neurooncol Pract 10:50\u201361","journal-title":"Neurooncol Pract"},{"key":"4872_CR21","doi-asserted-by":"publisher","unstructured":"Wanis HA, M\u00f8ller H, Ashkan K, Davies EA (2023) The influence of ethnicity on Survival from Malignant Primary Brain tumours in England: a Population-based Cohort Study. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/CANCERS15051464","DOI":"10.3390\/CANCERS15051464"},{"key":"4872_CR22","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/cncr.21539","volume":"104","author":"I Chakrabarti","year":"2005","unstructured":"Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974\u20131999. Cancer 104:2798\u20132806. https:\/\/doi.org\/10.1002\/cncr.21539","journal-title":"Cancer"},{"key":"4872_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12017-021-08659-x","volume":"24","author":"J Lee","year":"2022","unstructured":"Lee J, Kay K, Troike K et al (2022) Sex differences in Glioblastoma Immunotherapy Response. Neuromolecular Med 24:50\u201355. https:\/\/doi.org\/10.1007\/s12017-021-08659-x","journal-title":"Neuromolecular Med"},{"key":"4872_CR24","first-page":"399","volume":"8","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, Bhurgri Y, Sadiq S, Shakoor KA (2007) Pediatric brain tumours at a tertiary care hospital in Karachi. Asian Pac J Cancer Prev 8:399\u2013404","journal-title":"Asian Pac J Cancer Prev"},{"key":"4872_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1215\/15228517-2008-097","volume":"11","author":"RS Arora","year":"2009","unstructured":"Arora RS, Alston RD, Eden TOB et al (2009) Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol 11:403\u2013413. https:\/\/doi.org\/10.1215\/15228517-2008-097","journal-title":"Neuro Oncol"},{"key":"4872_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jjco\/hyq204","volume":"41","author":"E Nomura","year":"2011","unstructured":"Nomura E, Ioka A, Tsukuma H (2011) Trends in the incidence of primary intracranial tumors in Osaka, Japan. Jpn J Clin Oncol 41:291\u2013294. https:\/\/doi.org\/10.1093\/jjco\/hyq204","journal-title":"Jpn J Clin Oncol"},{"key":"4872_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00381-006-0198-0","volume":"23","author":"M Mehrazin","year":"2007","unstructured":"Mehrazin M, Yavari P (2007) Morphological pattern and frequency of intracranial tumors in children. Childs Nerv Syst 23:157\u2013162. https:\/\/doi.org\/10.1007\/s00381-006-0198-0","journal-title":"Childs Nerv Syst"},{"key":"4872_CR28","doi-asserted-by":"publisher","unstructured":"Keenan BP, Barr E, Gleeson E et al (2023) Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist. https:\/\/doi.org\/10.1200\/EDBK_391516","DOI":"10.1200\/EDBK_391516"},{"key":"4872_CR29","doi-asserted-by":"publisher","unstructured":"Din NU, Ukoumunne OC, Rubin G et al (2015) Age and gender variations in Cancer Diagnostic intervals in 15 cancers: analysis of data from the UK Clinical Practice Research Datalink. PLoS ONE 10. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0127717","DOI":"10.1371\/JOURNAL.PONE.0127717"},{"key":"4872_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3909\/riog0107","volume":"3","author":"J Varughese","year":"2010","unstructured":"Varughese J, Richman S (2010) Cancer Care Inequity for women in Resource-Poor Countries. Rev Obstet Gynecol 3:122. https:\/\/doi.org\/10.3909\/riog0107","journal-title":"Rev Obstet Gynecol"},{"key":"4872_CR31","doi-asserted-by":"publisher","unstructured":"Rattani SA, Dahlke S, Cameron B (2022) Cancer Care in Pakistan: A Descriptive Case Study. 101177\/23333936221080988 9. https:\/\/doi.org\/10.1177\/23333936221080988","DOI":"10.1177\/23333936221080988"},{"key":"4872_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/J.TRECAN.2021.12.007","volume":"8","author":"K Shah","year":"2022","unstructured":"Shah K, Zafar SY, Chino F (2022) Role of financial toxicity in perpetuating health disparities. Trends Cancer 8:266\u2013268. https:\/\/doi.org\/10.1016\/J.TRECAN.2021.12.007","journal-title":"Trends Cancer"},{"key":"4872_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13690-020-00497-w","volume":"78","author":"AD Azad","year":"2020","unstructured":"Azad AD, Charles AG, Ding Q et al (2020) The gender gap and healthcare: associations between gender roles and factors affecting healthcare access in Central Malawi, June\u2013August 2017. Archives Public Health 78:119. https:\/\/doi.org\/10.1186\/s13690-020-00497-w","journal-title":"Archives Public Health"},{"key":"4872_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10552-014-0496-x","volume":"26","author":"AB Porter","year":"2015","unstructured":"Porter AB, Lachance DH, Johnson DR (2015) Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control 26:179\u2013185. https:\/\/doi.org\/10.1007\/s10552-014-0496-x","journal-title":"Cancer Causes Control"},{"key":"4872_CR35","doi-asserted-by":"publisher","unstructured":"Gorenflo MP, Shen A, Murphy ES et al (2023) Area-level socioeconomic status is positively correlated with glioblastoma incidence and prognosis in the United States. Front Oncol 2023;13:1110473. https:\/\/doi.org\/10.3389\/fonc.2023.1110473","DOI":"10.3389\/fonc.2023.1110473"},{"key":"4872_CR36","first-page":"5515","volume":"32","author":"J Kerschbaumer","year":"2012","unstructured":"Kerschbaumer J, Freyschlag CF, Bauer R et al (2012) Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study. Anticancer Res 32:5515\u20135519","journal-title":"Anticancer Res"},{"key":"4872_CR37","doi-asserted-by":"publisher","first-page":"106909","DOI":"10.1016\/j.clineuro.2021.106909","volume":"209","author":"CE Bird","year":"2021","unstructured":"Bird CE, Traylor JI, Youssef M, Abdullah KG (2021) Distance traveled to glioblastoma treatment: a measure of the impact of socioeconomic status on survival. Clin Neurol Neurosurg 209:106909. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106909","journal-title":"Clin Neurol Neurosurg"},{"key":"4872_CR38","doi-asserted-by":"publisher","unstructured":"Corden E, Siddiqui SH, Sharma Y et al (2021) Distance from Healthcare Facilities Is Associated with increased morbidity of Acute infection in Pediatric patients in Matiari, Pakistan. Int J Environ Res Public Health 18. https:\/\/doi.org\/10.3390\/ijerph182111691","DOI":"10.3390\/ijerph182111691"},{"issue":"Suppl 4","key":"4872_CR39","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.47391\/JPMA.11-S4-AKUB04","volume":"72","author":"MH Bajwa","year":"2022","unstructured":"Bajwa MH, Shah MM, Khalid MU et al (2022) Distance travelled for brain tumour surgery: an low and middle Income Country\u2019s perspective. J Pak Med Assoc 72(Suppl 4):S25\u2013S33. https:\/\/doi.org\/10.47391\/JPMA.11-S4-AKUB04","journal-title":"J Pak Med Assoc"},{"key":"4872_CR40","doi-asserted-by":"publisher","first-page":"vdab053","DOI":"10.1093\/noajnl\/vdab053","volume":"3","author":"DMJ M\u00fcller","year":"2021","unstructured":"M\u00fcller DMJ, De Swart ME, Ardon H et al (2021) Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study. Neurooncol Adv 3:vdab053. https:\/\/doi.org\/10.1093\/noajnl\/vdab053","journal-title":"Neurooncol Adv"},{"key":"4872_CR41","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/cncr.29957","volume":"122","author":"BM Ellingson","year":"2016","unstructured":"Ellingson BM, Nguyen HN, Lai A et al (2016) Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer 122:1718\u20131727. https:\/\/doi.org\/10.1002\/cncr.29957","journal-title":"Cancer"},{"key":"4872_CR42","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/neuonc\/nov029","volume":"17","author":"AL Stensj\u00f8en","year":"2015","unstructured":"Stensj\u00f8en AL, Solheim O, Kvistad KA et al (2015) Growth dynamics of untreated glioblastomas in vivo. Neuro Oncol 17:1402\u20131411. https:\/\/doi.org\/10.1093\/neuonc\/nov029","journal-title":"Neuro Oncol"},{"key":"4872_CR43","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.clon.2007.01.373","volume":"19","author":"BM James","year":"2007","unstructured":"James BM, Gillard JH, Antoun NM et al (2007) Glioblastoma doubling time and cellular proliferation markers. Clin Oncol 19:S33","journal-title":"Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04872-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:08:11Z","timestamp":1735862891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04872-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4872"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04872-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the Ethical Review Committee (ID: 2020-3529-10977).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent was not required as data was retrospectively gathered.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}